Filing Details
- Accession Number:
- 0001209191-19-061939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-26 16:25:50
- Reporting Period:
- 2019-12-20
- Accepted Time:
- 2019-12-26 16:25:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621334 | Pat Cotroneo | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Svp, Finance And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-20 | 18,000 | $3.50 | 271,788 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-20 | 21,000 | $5.95 | 292,788 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-12-20 | 17,254 | $14.58 | 310,042 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-20 | 46,727 | $45.51 | 263,315 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-12-20 | 12,729 | $46.27 | 250,586 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 18,000 | $0.00 | 18,000 | $3.50 |
| Common Stock | Stock Optin (Right to Buy) | Disposition | 2019-12-20 | 21,000 | $0.00 | 21,000 | $5.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-20 | 17,254 | $0.00 | 17,254 | $14.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-06-07 | No | 4 | M | Direct | |
| 0 | 2022-06-27 | No | 4 | M | Direct | |
| 0 | 2024-03-19 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $44.91 to $45.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $45.91 to $46.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
